Scinai Immunotherapeutics Stock to Reverse Split on Tuesday, May 21st (NASDAQ:SCNI)

Shares of Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) are scheduled to reverse split before the market opens on Tuesday, May 21st. The 1-10 reverse split was announced on Tuesday, May 21st. The number of shares owned by shareholders will be adjusted after the closing bell on Tuesday, May 21st.

Scinai Immunotherapeutics Trading Up 2.3 %

Shares of NASDAQ SCNI opened at $0.45 on Thursday. Scinai Immunotherapeutics has a 12 month low of $0.43 and a 12 month high of $2.27. The stock has a 50 day moving average of $0.48 and a 200-day moving average of $0.56. The company has a market capitalization of $841,313.00, a P/E ratio of -0.14 and a beta of 2.45.

About Scinai Immunotherapeutics

Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications.